Related Experiment Video
Updated: Jun 26, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B
Elizabeth Hopper-Borge1, Xiu Xu, Tong Shen
1Medical and Basic Science Divisions, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Abstract:
Multidrug resistance protein 7 (MRP7; ABCC10) is an ATP-binding cassette transporter which is able to transport amphipathic anions and confer resistance to docetaxel and, to a lesser extent, vincristine and paclitaxel. Whereas some detail on the resistance profile of MRP7 is known, the activities of the pump have not been completely determined. Here, it is shown by the analysis of MRP7-transfected HEK293 cells that, in addition to natural product agents, MRP7 is also able to confer resistance to nucleoside-based agents, such as the anticancer agents cytarabine (Ara-C) and gemcitabine, and the antiviral agents 2',3'-dideoxycytidine and PMEA. Consistent with the operation of an efflux pump, expression of MRP7 reduced the accumulation of Ara-C and PMEA. In addition, MRP7 is also able to confer resistance to the microtubule-stabilizing agent epothilone B. Ectopic expression of MRP7 in mouse embryo fibroblasts deficient in P-glycoprotein and Mrp1 revealed that MRP7 has a broad resistance profile for natural product agents. In this drug-sensitive cellular background, MRP7 conferred high levels of resistance to docetaxel (46-fold), paclitaxel (116-fold), SN-38 (65-fold), daunorubicin (7.5-fold), etoposide (11-fold), and vincristine (56-fold). Buthionine sulfoximine did not attenuate MRP7-conferred resistance to docetaxel or Ara-C. These experiments indicate that the resistance capabilities of MRP7 include nucleoside-based agents and a range of natural product anticancer agents that includes nontaxane antimicrotubule agents that are not susceptible to P-glycoprotein-mediated transport and that, unlike MRP1 and MRP2, MRP7-mediated drug transport does not involve glutathione.
Insights
Multidrug resistance protein 7 (MRP7) confers resistance to anticancer drugs like docetaxel and nucleoside agents such as cytarabine. This efflux pump
Area of Science:
- Molecular Biology
- Pharmacology
- Cancer Research
Background:
- Multidrug resistance protein 7 (MRP7; ABCC10) is an ATP-binding cassette transporter.
- MRP7 confers resistance to certain chemotherapy drugs, but its full substrate profile is not well-defined.
Purpose of the Study:
- To comprehensively characterize the drug resistance profile of MRP7.
- To determine if MRP7 transports nucleoside-based agents and other natural products.
Main Methods:
- Analysis of MRP7-transfected HEK293 cells.
- Ectopic expression of MRP7 in drug-sensitive mouse embryo fibroblasts (deficient in P-glycoprotein and Mrp1).
- Drug accumulation assays for cytarabine (Ara-C) and PMEA.
- Assessment of resistance levels to various anticancer agents.
Main Results:
- MRP7 confers resistance to nucleoside-based agents (cytarabine, gemcitabine) and antiviral nucleosides (2',3'-dideoxycytidine, PMEA).
- MRP7 expression reduced the intracellular accumulation of Ara-C and PMEA, consistent with an efflux mechanism.
- MRP7 demonstrated broad resistance to natural product anticancer agents, including high resistance to docetaxel (46-fold), paclitaxel (116-fold), SN-38 (65-fold), and vincristine (56-fold).
- Resistance to docetaxel and Ara-C was not affected by buthionine sulfoximine, indicating glutathione independence.
Conclusions:
- MRP7 possesses a broad drug resistance profile, extending beyond known substrates to include nucleoside-based agents.
- MRP7 mediates the transport of natural product anticancer agents, including non-taxane antimicrotubules, independent of P-glycoprotein.
- MRP7-mediated drug transport does not involve glutathione, differentiating it from MRP1 and MRP2.
More Related Videos
Related Concept Videos
ABC Transporters: Exporter
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Treatment Resistant Cancers
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:

